Drawing for SCÉIL

USPTO serial 79143384

SCÉIL

Reviewed by CopyMark Law Group

Reg. 5211208Status 404
Filing date
Status date
Registration date
May 30, 2017
Examiner
TURNER, LAUREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SCÉIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for medical, therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; chemical and biochemical preparations for medical, therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; chemical pharmaceutical products, namely, chemical preparations for pharmaceutical purposes for treating cancer, pharmaceutical preparations for use in chemotherapy, engineered stem cells for use in regenerative medicine; cultures and preparations of micro-organisms for medical or therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; bacteriological preparations for medical, therapeutic, pharmaceutical and veterinary useSECTION 71 - CANCELLED—
042Scientific and industrial research, namely, research and development of new products, biological research, bacteriological research, chemistry research, technical research in the field of storage and therapeutic uses of human or animal cells, scientific research for medical, therapeutic and diagnostic purposes; scientific research in the field of storage and therapeutic uses of human or animal cells; scientific research for medical and veterinary purposes in the field of storage and therapeutic uses of human or animal cells; scientific analysis in the field of storage and potential autologous therapeutic purposes; research and development of biochemical analysis, biological analysis and molecular biology techniques, namely, research in the field of storage and therapeutic uses of human or animal cells; research and development of new molecules for use in industry, preparation of biological materials, particularly of stem cells, namely, biological engineering, genetic engineering; scientific laboratory services; technical project studies, namely, engineering, surveying, computer programming, design and development of software and multimedia products, all the aforesaid services exclusively intended for storage and/or therapeutic uses of human or animal cells; scientific and industrial research and development in the fields of genetic, medical and veterinary diagnostics and biotechnology; chemical, biochemical and biotechnological laboratory services; scientific advice in the field of biotechnologySECTION 71 - CANCELLED—
044Collection and preservation of human blood; medical services relating to the collection, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical services, namely, sampling, collection and banking of human cells for therapeutic purposes; blood bank services; collection and storage of human cells and blood, rental of medical equipmentSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 17, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 15, 2023C71TCANCELLED SECTION 71—
Nov 12, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 5, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 27, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 6, 2017GPNXNOTIFICATION PROCESSED BY IB—
Sep 7, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 7, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 30, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 30, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 22, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 22, 2017NPUBNOTICE OF PUBLICATION—
Feb 9, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2016DOCKASSIGNED TO EXAMINER—
Dec 9, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 9, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2016CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 29, 2015RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 28, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 12, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2015OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 26, 2015DOCKASSIGNED TO EXAMINER—
Apr 23, 2015RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 16, 2014CNSLLETTER OF SUSPENSION MAILED—
Oct 15, 2014CNSLSUSPENSION LETTER WRITTEN—
Sep 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2014ALIEASSIGNED TO LIE—
Sep 15, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 14, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 14, 2014RFRRREFUSAL PROCESSED BY MPU—
Mar 14, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 13, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 7, 2014DOCKASSIGNED TO EXAMINER—
Mar 7, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 6, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance